Vitamin D supplementation significantly improves colorectal cancer survival

  • Vaughan-Shaw PG & al.
  • Br J Cancer
  • 15 Sep 2020

  • curated by Dawn O'Shea
  • UK Medical News
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Research from the University of Edinburgh suggests vitamin D supplementation improves survival for patients with colorectal cancer (CRC).

The team searched PubMed and Web of Science for randomised controlled trials (RCTs) of vitamin D supplementation reporting CRC mortality. RCTs with high risk of bias were excluded from the analysis.

Seven RCTs (n=957 CRC cases) were identified. Three trials included patients with CRC at outset, and four population trials reported survival in incident cases. Two RCTs were excluded from meta-analysis.

Although trials varied in inclusion criteria, intervention dose and outcomes, meta-analysis found a 30 per cent reduction in adverse CRC outcomes with supplementation (HR, 0.70; 95% CI, 0.48-0.93).

The effect on survival was consistently observed in sub-group analyses both in trials specifically including CRC patients and in population trials reporting outcomes in incident CRC cases.

A beneficial effect on progression-free survival was seen in trials of CRC patients (HR, 0.65; 95% CI, 0.36-0.94), with suggestive effect in incident CRC cases from population trials (CRC-specific survival: HR, 0.76; 95% CI, 0.39-1.13).

No heterogeneity or publication bias was noted.

This is the first systematic review with meta-analysis of randomised controlled trials to examine the effect of vitamin D supplementation on survival outcomes in patients with CRC.

The meta-analysis demonstrates a clinically meaningful benefit of vitamin D supplementation on CRC survival outcomes.